Osborne Clarke LLP
Please see full biography at osborneclarke.com/lawyers/arty-rajendra/
A team noted for its deep sector expertise, Osborne Clarke LLP’s practice has recently been involved in mandates involving FRAND and SEP litigation. Experienced litigation specialist Arty Rajendra leads the department, while Tim Harris is noted for his expertise in the life sciences, pharma and biotech sectors. Will James bolsters the practice with his capabilities in handling litigation for large tech-driven companies, notably in the life sciences, electronics and medical devices fields. Trevor Crosse joined from Marks & Clerk in October 2022.
Legal 500 Editorial commentary
Key clients
- Optis
- Amgen
- Innovius
- Anstar Limited
- Escaux NV
- Santen
- Kantar Group
Work highlights
- Acted for Optis in its high-profile multi-trial telecoms FRAND dispute with Apple.
- Advising Amgen in relation to multiple biopharma disputes, including its global litigation with Sanofi and Regeneron relating to cholesterol-lowering antibodies.
- Advised Escaux NV, a subsidiary of Destiny NV, in relation to a patent dispute concerning web-enabled telecommunication systems.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
The lawyer(s) leading their teams.
Arty Rajendra